Clinical Trial Update: Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema. [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating topical bromfenac ophthalmic solution for acute post-operative cystoid macular edema has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystoid Macular Edema

Drugs mentioned

• Topical Bromfenac Ophthalmic Solution 0.09% (bromfenac)

Snippet

Sponsor: Johns Hopkins University | Conditions: Cystoid Macular Edema | Phase 2 | Status: WITHDRAWN